DECISION ON ISSUE OF OPTIONS TO SUBSCRIBE FOR SHARES IN SCN
On January 29, 2007, a general meeting in Scandinavian Clinical Nutrition i Sverige AB (publ) resolved to issue options to subscribe for shares in the company.
The issue is constructed as an incentive program for the senior management and members of the board. The options can be exercised during September, 2008, and the subscription price is set to SEK 15 per share. For each option subscribed for, the subscriber will pay a premium of SEK 2.46 to the company.
CEO Ulf Söderberg, email@example.com, +46 708 13 22 81
Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Membraseven and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth both in Sweden and on the company’s export markets. The SCN share is listed for trade on NGM Nordic MTF since December 6, 2006.